Serene Forest

Saturday, February 7, 2026

Normokalemic Periodic Paralysis Exists

 


๐ŸŒฌ️
Normokalemic Periodic Paralysis Exists

Why “Normal Potassium” Does Not Rule Out Periodic Paralysis

By Susan Q. Knittle-Hunter
Founder, Periodic Paralysis Network, Inc.
Author, Advocate, and Patient Living With Periodic Paralysis


Introduction: The Myth That Won’t Die

People with Periodic Paralysis are still being told—often emphatically—that Normokalemic Periodic Paralysis (NormoKPP) does not exist.
This claim is usually delivered with confidence, citations to older conference talks, and the assertion that “normal potassium means it must be something else.”

That position is incomplete—and increasingly incorrect.

Normokalemic PP is not a misunderstanding by patients. It is a real clinical presentation, documented for decades, explained by ion-channel dysfunction, and supported by both historical and modern research, including identified genetic mutations.

This article exists so patients can finally say, “Here is the evidence.”


What Is Normokalemic Periodic Paralysis?

Normokalemic Periodic Paralysis describes episodic weakness or paralysis occurring without serum potassium levels leaving the laboratory reference range.

Key point:

Periodic Paralysis is a channelopathy—not a potassium disorder.

Potassium shifts may modulate attacks, but they are not required for paralysis to occur.

Core features may include:

  • Episodic weakness or paralysis
  • “Spellish” prodromes (fog, heaviness, shakiness)
  • Cold sensitivity
  • Post-exertional weakness
  • Normal potassium during attacks
  • Normal EMG or ECG between attacks
  • Missed or negative genetic tests

This presentation has been documented since the 1940s and 1950s, long before modern genetics—and continues to be documented today.


๐Ÿง  Why Normal Potassium Does NOT Exclude PP

Multiple authoritative sources confirm:

Potassium does not have to leave the normal range to cause serious or life-threatening paralysis.

From Muscular Dystrophy UK:

“It has recently been discovered that it is not the change in blood potassium level that is the primary problem… other factors separate from blood potassium can also worsen the function of the pores, so a change in blood potassium is not essential.”

From Talbot (1941) and later reviews of 400+ cases:

  • Paralysis occurred with consistently normal potassium
  • ECGs could remain normal during attacks
  • Severity did not correlate with potassium level
  • Death was reported in extreme paralysis without hypokalemia

From modern summaries:

“The total body store of potassium is usually normal; it is just in the wrong place.”


๐Ÿงฌ Yes — There IS a Genetic Basis for NormoKPP

A common claim is that NormoKPP “was really just HyperKPP.”

That claim fails when newer genetics are considered.

๐Ÿ”ฌ Calcium Channel–Related Normokalemic PP

A landmark study by Fan et al., including Lehmann-Horn, identified a calcium channel mutation causing complicated normokalemic periodic paralysis:

Gene: CACNA1C / CaV1.1
Mechanism: Omega-pore current through mutant calcium channels
Conclusion (authors’ words):

“This study shows for the first time… the first calcium channel mutation for complicated normokalaemic periodic paralysis.”

๐Ÿ“Œ This alone disproves the claim that NormoKPP “does not exist.”


๐Ÿง  Normokalemia Occurs Across PP Subtypes

Normokalemic attacks are documented in:

  • Hyperkalemic PP
  • Hypokalemic PP
  • Andersen-Tawil Syndrome
  • Paramyotonia Congenita
  • Calcium-channel–related PP

From ATS literature:

“Attack frequency, duration and severity may not correlate with ictal serum potassium levels, which may be reduced, normal, or elevated.”

This is why serum potassium alone is an unreliable diagnostic gatekeeper.


⚠️ Why Testing Often Fails These Patients

Genetic Testing

  • Current panels do not cover all pathogenic variants
  • Many patients have variants of unknown significance
  • Negative testing ≠ no channelopathy

EMG / Long Exercise CMAP

  • Sensitivity ~60% at best
  • Can be normal between attacks
  • Normal results do not exclude metabolic or channel myopathies

As stated in Electrodiagnostic Evaluation of Myopathies:

“Normal EDX studies do not necessarily rule out the presence of a myopathy.”


๐ŸŒ€ The “Spellish” Prodrome: Early Warning, Not Anxiety

Patients often describe:

  • Fog or disconnection
  • Shakiness or coldness
  • Sudden fatigue
  • A sense that “something is coming”

These are early ion-channel destabilizations, not psychological symptoms.

Importantly:

  • Lying down or resting can worsen attacks
  • Gentle activity or mental engagement may abort them
  • Cold exposure frequently triggers symptoms

This pattern is classic PP physiology.


Why Dismissing NormoKPP Causes Harm

When doctors insist NormoKPP “doesn’t exist,” patients are:

  • Misdiagnosed with FND or anxiety
  • Given contraindicated medications
  • Denied anesthesia precautions
  • Left untreated for a genetic channelopathy

The cost is real morbidity—and sometimes death.


๐Ÿงพ Clinical Bottom Line for Physicians

  • Periodic Paralysis is a mineral metabolic channelopathy
  • Normal potassium does not exclude PP
  • Normokalemic attacks are well-documented historically and currently
  • Calcium channel mutations do cause normokalemic PP
  • Testing limitations are real
  • Clinical pattern matters

The correct response is not dismissal, but clinical humility.


๐Ÿ“š Selected References

  • Fan C. et al. Complicated normokalaemic periodic paralysis due to a Ca(v)1.1 mutation. PubMed: 24240197
  • Talbot JH. Studies in Disorders of Muscle. JCI 1941
  • Tyler FH et al. Periodic Paralysis Without Hypopotassemia. JCI 1951
  • Muscular Dystrophy UK. Periodic Paralyses Overview
  • Oxford Brain Journal. Andersen-Tawil Syndrome
  • Medscape: Periodic Paralysis Workup
  • Paganoni & Amato. Electrodiagnostic Evaluation of Myopathies

(Full reference list available via Periodic Paralysis Network, Inc.)



๐Ÿ“š Appendix: Key Evidence Supporting Normokalemic Periodic Paralysis


1️ Historical Clinical Documentation (Pre-Genetic Era)

These papers document classic periodic paralysis with normal potassium, long before modern genetic testing:

  • Talbot JH (1941) – Review of >400 cases showing paralysis without hypokalemia
  • Tyler FH et al. (1951)Periodic paralysis without hypopotassemia
  • JAMA Neurology (1963) – Normokalemic PP identified as a muscle disorder, not psychiatric

๐Ÿ‘‰ These papers establish Normokalemic PP as a clinical entity independent of lab potassium.


2️ Modern Channelopathy Understanding

These sources explain why potassium may remain normal:

  • Muscular Dystrophy UK – PP as an ion-channel disorder, not a potassium disease
  • Wikipedia (summary of peer-reviewed literature) – Potassium distribution vs serum levels
  • Medscape – PP workup acknowledging normal potassium during attacks

๐Ÿ‘‰ Mechanism matters more than serum potassium.


3️ Genetic Evidence (Calcium Channel Involvement)

  • Fan C. et al., including Lehmann-Horn F.
    First calcium-channel mutation linked to complicated normokalemic PP
    PubMed ID: 24240197

๐Ÿ‘‰ Direct refutation of the claim that no genetic basis exists.


4️ Normal Testing Does NOT Exclude PP

  • Paganoni & Amato – Normal EMG does not rule out metabolic myopathies
  • MDA Quest Magazine – PP described as an endocrine/metabolic myopathy

๐Ÿ‘‰ Negative tests ≠ absence of disease.


5️ Normokalemia Across PP Subtypes

  • Andersen-Tawil Syndrome literature – Attacks occur with low, normal, or high K
  • HyperPP and HypoPP studies – Potassium may stay in normal range during attacks

๐Ÿ‘‰ Normokalemia is a phenotype, not a diagnosis error.


๐Ÿ’™ Final Word to Patients

If your potassium is normal and your body is failing you anyway—you are not wrong, not imagining it, and not alone.

Normokalemic Periodic Paralysis exists.
And your lived experience already proved it—long before medicine caught up.

With warmth and resolve,
Susan Q. Knittle-Hunter

Friday, January 30, 2026

Why Some People With Periodic Paralysis Need Oxygen (Update)


Why Some People With Periodic Paralysis Need Oxygen  (Update) 

(Even When Oxygen Saturation Looks “Normal”)

Weekly Question:
Do you use oxygen, have you used it in the past, or do you feel you need it?

If you answered yes — or “I think I do, but my numbers don’t show it” — you are not alone, and you are not imagining things.

For people with the varying forms of Periodic Paralysis (PP) (channelopathies, also known as, mineral metabolic disorders), oxygen needs are often misunderstood, dismissed, or denied because standard medical criteria were never designed for mineral metabolic disorders.

This article explains why oxygen may still be necessary or helpful, even when pulse oximetry appears “normal.”


1. Periodic Paralysis Is Not Just a Muscle Disease

Periodic Paralysis is a genetic ion-channel disorder (mineral metabolic disorder) that affects:

  • Skeletal muscles (movement and strength)
  • Respiratory muscles (breathing)
  • The autonomic nervous system
  • Cardiac electrical signaling

In conditions such as Andersen-Tawil Syndrome, Hyperkalemic Periodic Paralysis, Hypokalemic Periodic Paralysis, and overlap channelopathies, muscle weakness and fatigue can involve the diaphragm and accessory breathing muscles, not just arms and legs.

This is critical - because breathing is muscle work.


2. Pulse Oximetry Does Not Measure What PP Patients Struggle With

Most doctors and insurance systems rely on SpO₂ (oxygen saturation) numbers to determine whether oxygen is “needed.”

But pulse oximeters only measure:

  • The percentage of oxygen bound to hemoglobin

They do not measure:

  • How effectively oxygen is delivered to tissues
  • How well respiratory muscles are functioning
  • Carbon dioxide (CO₂) retention
  • Cardiac output
  • Autonomic instability
  • Neuromuscular fatigue

A person with PP can have:

  • SpO₂ readings of 96–99%
  • And still experience:
    • Air hunger
    • Shortness of breath
    • Chest heaviness
    • Rapid fatigue
    • Post-exertional collapse
    • Poor sleep and morning weakness

This is functional hypoxia, not lung disease.


3. Oxygen Delivery Depends on More Than Saturation

Oxygen delivery is determined by:

Oxygen content × Cardiac output

In PP patients, delivery can be impaired by:

  • Weak respiratory muscles
  • Shallow breathing
  • Autonomic dysfunction
  • Bradycardia or arrhythmias
  • Poor heart rate response to exertion
  • Reduced blood flow during fatigue

Even with “normal” saturation, oxygen may not reach muscles, brain, or heart tissue efficiently.


4. CO₂ Retention: The Invisible Problem

Many PP patients experience CO₂ retention, especially during:

  • Sleep
  • Rest
  • Post-exertional fatigue
  • Respiratory muscle weakness

CO₂ retention:

  • Does not show on pulse oximetry
  • Can cause air hunger, headache, confusion, anxiety-like symptoms
  • Makes breathing feel “unsatisfying” or labored

This is one reason oxygen can feel helpful even when saturation appears normal — it reduces respiratory workload and improves gas exchange efficiency.


5. Exertion, Permanent Muscle Weakness, and Oxygen

Many people with PP develop permanent muscle weakness (PMW) and exercise intolerance over time.

During exertion:

  • Muscles require more oxygen
  • PP muscles are inefficient at energy use
  • Cardiac response may be blunted
  • Fatigue occurs quickly
  • Recovery is prolonged

Supplemental oxygen can:

  • Reduce muscle oxygen debt
  • Lessen post-exertional crashes
  • Support respiratory muscles
  • Improve endurance for daily activities
  • Help patients remain upright and functional longer

This is supportive care, not treatment of lung disease.


6. Why Medicare and Insurance Often Deny Oxygen for PP

Medicare and most insurers require:

  • Sustained SpO₂ ≤ 88% at rest or exertion

These criteria:

  • Were developed for COPD and lung disease
  • Do not account for mineral metabolic disorders, ion channelopathies, or neuromuscular disorders
  • Do not measure intermittent, positional, or exertional hypoxia
  • Do not assess CO₂ retention or muscle fatigue

As a result, many PP patients:

  • Previously benefited from oxygen
  • Lose coverage despite worsening symptoms
  • Are told “you don’t qualify” even when function declines

This is a system failure, not a patient failure.


7. Oxygen as Support — Not a Cure

For PP patients, oxygen is often used:

  • At low flow
  • Intermittently
  • During exertion
  • During recovery
  • Sometimes at night

Oxygen does not:

  • Cure PP
  • Reverse muscle weakness
  • Prevent all attacks

But it can:

  • Reduce physiological stress
  • Support compromised systems
  • Improve quality of life
  • Reduce fear and breath-related distress

For medication-intolerant patients, oxygen may be one of the few safe supportive options available.


8. Talking to Doctors or Oxygen Suppliers

A helpful way to explain the need:

“I have a genetic neuromuscular channelopathy. My oxygen issue is related to impaired delivery and utilization due to muscle weakness and autonomic dysfunction, not lung disease. Pulse oximetry alone does not reflect my functional oxygen needs.”

When speaking with suppliers such as Inogen, it can help to clarify that oxygen is being sought for neuromuscular support, not COPD.


9. Listening to Your Body Matters

Many PP patients know they need oxygen because:

  • Symptoms improve with use
  • Recovery is easier
  • Exertion becomes more tolerable
  • Air hunger decreases
  • Sleep quality improves

These experiences are valid clinical information, even when they don’t fit rigid criteria.


Final Thoughts

If you feel you need oxygen:

  • You are not weak
  • You are not exaggerating
  • You are not “just anxious”
  • And you are not alone

Periodic Paralysis is complex, systemic, and poorly understood. Supportive tools like oxygen are sometimes necessary because the disease affects more than what standard tests can measure.

Listening to your body — and advocating for yourself — is not optional with PP. It is survival.


References & Further Reading

  • Jurkat-Rott K, Lehmann-Horn F. Ion channels and periodic paralysis.
  • Sansone V et al. Respiratory involvement in neuromuscular disorders.
  • Statland JM et al. Clinical spectrum of skeletal muscle channelopathies.
  • Tawil R et al. Andersen–Tawil syndrome: clinical features and management.
  • McCool FD, Tzelepis GE. Respiratory muscle dysfunction in neuromuscular disease.
  • PPNI Publications by Susan Q. Knittle-Hunter (Living With Periodic Paralysis; The Periodic Paralysis Guide & Workbook; A Bill of Rights for Periodic Paralysis Patients)

Picture: Paralyzed woman with Periodic Paralysis using oxygen therapy.